Latest Breaking News On - Index lesion disease severity - Page 1 : comparemela.com

A cream formulation of ruxolitinib was deemed safe and effective compared with placebo in patients with cutaneous graft-versus-host disease.

Galina markovaCellular therapy meetingsInpatient consultative dermatologyDermatology serviceMemorial sloan kettering cancer centerGlobal assessmentClinical conditionComposite assessmentIndex lesion disease severityDermtech smartCream formulation of ruxolitinibPatients with cutaneous graft versus host disease